Mr
Mark
Lunt

Consultant

Sheffield Office

Telephone. +44(0) 114 274 3700
Mobile. +44(0) 773 966 7587
Email. [email protected]

Experience

40 years since qualifying as a patent attorney, Mark has worked both in industry, firstly in the oil industry with Burmah-Castrol, then in the power tools field with Black & Decker, and in private practice for any client willing to pay! Mark has learned that clients want to know their options, but also to get a positive recommendation on a course of action. This means getting to know your business, and what you are trying to achieve through your intellectual property.

Mark is gregarious and inquisitive, and will get to the bottom of what needs to be done in connection with your IP matters. He will let you know the anticipated costs and, once he has your approval, he will get it done promptly and efficiently. And if Mark can't do it himself, he has a great team of professionals around him to whom he can refer legal, trade mark or other technology areas of patent practice.

Mark handles engineering inventions, but where these have chemical or electronic elements, that is no problem given his broad scientific knowledge. Mark has also developed expertise in handling designs, that is, the appearance of products, as opposed to what they do.

Specialisms

  • Automotive systems
  • Oil & gas

Industries

  • Aerospace & defence icon Aerospace & defence
  • Automotive icon Automotive
  • Energy icon Energy
  • Medical devices icon Medical devices

Services

  • Patents
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

Oceanography and Zoology

CSR

Mark is a director of Pamia Limited, which is the mutual insurance company run by the patent profession and which insures 97% of the patent and trade mark attorney profession in the United Kingdom.

The company indemnifies HGF, and all insured members, against claims that may be made when things go wrong. Unfortunately, this is just a fact of life, and despite the best endeavours of any firm or individual, mistakes do occasionally get made which can result in losses for our clients.

With assets in excess of £20million, and close links with the insurance markets, Pamia provides a first layer of insurance for its members, with excess layers provided by the general insurance market. The Board of Directors is made up of individuals from members firms who are advised by the managers of Pamia, namely Thomas Miller Professional Indemnity Limited, who manage several mutual insurance companies. The Board, however, takes full responsibility for the company, including claims management as well as the investment of its assets.

Mark is Chair of the Rules & Terms of Cover committee, and a member of the Investment committee, both committees being answerable to the Board.

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details
Event - 25th May 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.